Skip to content
OpenCapital
Get started

Eledon Pharmaceuticals, Inc. ELDN Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Revenue$192.0K
EPS-$0.64Miss by $0.32
EPS estimate-$0.32

Next report

Aug 13, 2026 (In 2 weeks)
EPS estimate-$0.19

Versus estimates

Revenue

Q4 2024$192.0K

Diluted EPS

Q1 2026-$0.33Miss by $0.11Q4 2025-$0.10Beat by $0.10Q3 2025-$0.21Beat by $0.01Q2 2025-$0.13Beat by $0.10Q1 2025-$0.08Beat by $0.20
Q4 2024-$0.64Miss by $0.32

Ask the moment Eledon Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Eledon Pharmaceuticals, Inc. report Q4 2024 earnings?
Eledon Pharmaceuticals, Inc. (ELDN) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Eledon Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?
Eledon Pharmaceuticals, Inc. reported revenue of $192.0K and eps of $-0.64 for Q4 2024.
Did Eledon Pharmaceuticals, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.32 by $0.32.
Where can I find Eledon Pharmaceuticals, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-042754) directly on SEC EDGAR. The filing index links above go to sec.gov.